Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Transmission of HIV drug resistance: lessons from sensitive screening assays.
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
2015 Update of the Drug Resistance Mutations in HIV-1.
Primary resistance to integrase strand-transfer inhibitors in Europe.
Determinants of virological failure and antiretroviral drug resistance in Mozambique.
Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
Patterns of transmitted HIV drug resistance in Europe vary by risk group.